BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Becerra MC, Swaminathan S. Commentary: a targets framework: dismantling the invisibility trap for children with drug-resistant tuberculosis. J Public Health Policy 2014;35:425-54. [PMID: 25209537 DOI: 10.1057/jphp.2014.35] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Garcia-Prats AJ, Schaaf HS, Hesseling AC. The safety and tolerability of the second-line injectable antituberculosis drugs in children. Expert Opin Drug Saf 2016;15:1491-500. [PMID: 27548570 DOI: 10.1080/14740338.2016.1223623] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
2 Tao NN, Li YF, Liu YX, Liu JY, Song WM, Liu Y, Geng H, Wang SS, Li HC. Epidemiological characteristics of pulmonary tuberculosis among children in Shandong, China, 2005-2017. BMC Infect Dis 2019;19:408. [PMID: 31077154 DOI: 10.1186/s12879-019-4060-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
3 Dheda K, Chang KC, Guglielmetti L, Furin J, Schaaf HS, Chesov D, Esmail A, Lange C. Clinical management of adults and children with multidrug-resistant and extensively drug-resistant tuberculosis. Clin Microbiol Infect 2017;23:131-40. [PMID: 27756712 DOI: 10.1016/j.cmi.2016.10.008] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 4.7] [Reference Citation Analysis]
4 Yuen CM, Jenkins HE, Chang R, Mpunga J, Becerra MC. Two methods for setting child-focused tuberculosis care targets. Public Health Action 2016;6:83-96. [PMID: 27358801 DOI: 10.5588/pha.16.0022] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
5 Srivastava S, Deshpande D, Pasipanodya JG, Thomas T, Swaminathan S, Nuermberger E, Gumbo T. A Combination Regimen Design Program Based on Pharmacodynamic Target Setting for Childhood Tuberculosis: Design Rules for the Playground. Clin Infect Dis 2016;63:S75-9. [PMID: 27742637 DOI: 10.1093/cid/ciw472] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
6 Jenkins HE. Global Burden of Childhood Tuberculosis. Pneumonia (Nathan) 2016;8:24. [PMID: 28003956 DOI: 10.1186/s41479-016-0018-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
7 Huynh J, Marais BJ. Multidrug-resistant tuberculosis infection and disease in children: a review of new and repurposed drugs. Ther Adv Infect Dis 2019;6:2049936119864737. [PMID: 31367376 DOI: 10.1177/2049936119864737] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
8 Deshpande D, Srivastava S, Nuermberger E, Koeuth T, Martin KR, Cirrincione KN, Lee PS, Gumbo T. Multiparameter Responses to Tedizolid Monotherapy and Moxifloxacin Combination Therapy Models of Children With Intracellular Tuberculosis. Clin Infect Dis 2018;67:S342-8. [PMID: 30496456 DOI: 10.1093/cid/ciy612] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
9 Khan PY, Yates TA, Osman M, Warren RM, van der Heijden Y, Padayatchi N, Nardell EA, Moore D, Mathema B, Gandhi N, Eldholm V, Dheda K, Hesseling AC, Mizrahi V, Rustomjee R, Pym A. Transmission of drug-resistant tuberculosis in HIV-endemic settings. Lancet Infect Dis 2019;19:e77-88. [PMID: 30554996 DOI: 10.1016/S1473-3099(18)30537-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 5.3] [Reference Citation Analysis]
10 Reuter A, Hughes J, Furin J. Challenges and controversies in childhood tuberculosis. The Lancet 2019;394:967-78. [DOI: 10.1016/s0140-6736(19)32045-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 6.7] [Reference Citation Analysis]
11 McQuaid CF, Cohen T, Dean AS, Houben RMGJ, Knight GM, Zignol M, White RG. Ongoing challenges to understanding multidrug- and rifampicin-resistant tuberculosis in children versus adults. Eur Respir J 2021;57:2002504. [PMID: 32855219 DOI: 10.1183/13993003.02504-2020] [Reference Citation Analysis]
12 Rahman MA, Sarkar A. Extensively Drug-resistant Tuberculosis (XDR-TB): A daunting challenge to the current End TB Strategy and policy recommendations. Indian J Tuberc 2017;64:153-60. [PMID: 28709481 DOI: 10.1016/j.ijtb.2017.03.006] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
13 Yuen CM, Rodriguez CA, Keshavjee S, Becerra MC. Map the gap: missing children with drug-resistant tuberculosis. Public Health Action 2015;5:45-58. [PMID: 26400601 DOI: 10.5588/pha.14.0100] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
14 Mckenna L, Frick M, Seaworth B, Furin J. The ‘invisibility’ of children with tuberculosis. J Public Health Pol 2015;36:123-5. [DOI: 10.1057/jphp.2014.48] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
15 Crook AM, Turkova A, Musiime V, Bwakura-Dangarembizi M, Bakeera-Kitaka S, Nahirya-Ntege P, Thomason M, Mugyenyi P, Musoke P, Kekitiinwa A, Munderi P, Nathoo K, Prendergast AJ, Walker AS, Gibb DM; ARROW Trial Team. Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy. BMC Med 2016;14:50. [PMID: 27004529 DOI: 10.1186/s12916-016-0593-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
16 Srivastava S, Pasipanodya JG, Ramachandran G, Deshpande D, Shuford S, Crosswell HE, Cirrincione KN, Sherman CM, Swaminathan S, Gumbo T. A Long-term Co-perfused Disseminated Tuberculosis-3D Liver Hollow Fiber Model for Both Drug Efficacy and Hepatotoxicity in Babies. EBioMedicine 2016;6:126-38. [PMID: 27211555 DOI: 10.1016/j.ebiom.2016.02.040] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 5.2] [Reference Citation Analysis]
17 van de Water BJ, Prvu Bettger J, Silva S, Humphreys J, Cunningham CK, Farley JE. Time to Drug-Resistant Tuberculosis Treatment in a Prospective South African Cohort. Glob Pediatr Health 2017;4:2333794X17744140. [PMID: 29226191 DOI: 10.1177/2333794X17744140] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
18 Esposito S, Bianchini S, Argentiero A, Neglia C, Principi N. How does one choose the appropriate pharmacotherapy for children with lower respiratory tract infections? Expert Opin Pharmacother 2020;21:1739-47. [PMID: 32567405 DOI: 10.1080/14656566.2020.1781091] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Malik R, Srivastava A, Yachha SK, Poddar U, Lal R. Childhood abdominal tuberculosis: Disease patterns, diagnosis, and drug resistance. Indian J Gastroenterol 2015;34:418-25. [PMID: 26678593 DOI: 10.1007/s12664-015-0582-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
20 Reuter A, Seddon JA, Marais BJ, Furin J. Preventing tuberculosis in children: A global health emergency. Paediatr Respir Rev 2020;36:44-51. [PMID: 32253128 DOI: 10.1016/j.prrv.2020.02.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Monedero I, Furin J. Programmatic management of children with drug-resistant tuberculosis: common sense and social justice. Public Health Action 2015;5:92. [PMID: 26393107 DOI: 10.5588/pha.15.0020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
22 Harausz EP, Garcia-Prats AJ, Seddon JA, Schaaf HS, Hesseling AC, Achar J, Bernheimer J, Cruz AT, D'Ambrosio L, Detjen A, Graham SM, Hughes J, Jonckheere S, Marais BJ, Migliori GB, McKenna L, Skrahina A, Tadolini M, Wilson P, Furin J; Sentinel Project on Pediatric Drug-Resistant Tuberculosis. New and Repurposed Drugs for Pediatric Multidrug-Resistant Tuberculosis. Practice-based Recommendations. Am J Respir Crit Care Med 2017;195:1300-10. [PMID: 27854508 DOI: 10.1164/rccm.201606-1227CI] [Cited by in Crossref: 41] [Cited by in F6Publishing: 13] [Article Influence: 8.2] [Reference Citation Analysis]